Træk
Fainting spell
Klinisk navn: Syncope
A transient loss of consciousness (i.e., characterized by a rapid onset, a short duration, and a spontaneous and complete recovery) due to cerebral hypoperfusion.
ReferencegenomGRCh38hg38
Positioner på gen- og variantsider følger dette valg i denne browser.
Read the genes linked to Fainting spell, and the rest of your genome, with one test.
Fra 449 $Gratis forsendelse · Resultater på 6–8 uger
Bestil min Genome Test139 gener knyttet til Fainting spell
Ændringer i disse gener forårsager sjældne tilstande, hvor Fainting spell ses. De fleste med dette træk har ingen af disse tilstande, og et gen på denne liste siger intet om nogens eget genom.
| Gen | Hvor ofte det ses | Tilstande |
|---|---|---|
| AKAP9A-kinase anchoring protein 9 | Altid | I 2 tilstande |
| ARHGEF15Rho guanine nucleotide exchange factor 15 | Altid | I 1 tilstand |
| CALM1calmodulin 1 | Altid | I 1 tilstand |
| CASQ2calsequestrin 2 | Altid | I 2 tilstande |
| CTSAcathepsin A | Altid | I 1 tilstand |
| GYS1glycogen synthase 1 | Altid | I 2 tilstande |
| HIVEP2HIVEP zinc finger 2 | Altid | I 1 tilstand |
| KCNE1potassium voltage-gated channel subfamily E regulatory subunit 1 | Altid | I 4 tilstande |
| KCNQ1potassium voltage-gated channel subfamily Q member 1 | Altid | I 7 tilstande |
| LMNAlamin A/C | Altid | I 2 tilstande |
| NOTCH3notch receptor 3 | Altid | I 1 tilstand |
| POPDC1popeye domain cAMP effector 1 | Altid | I 1 tilstand |
| SNTA1syntrophin alpha 1 | Altid | I 1 tilstand |
| CALM2calmodulin 2 | Meget ofte (80–99 %) | I 1 tilstand |
| HCN4hyperpolarization activated cyclic nucleotide gated potassium channel 4 | Meget ofte (80–99 %) | I 2 tilstande |
| KCNJ5potassium inwardly rectifying channel subfamily J member 5 | Meget ofte (80–99 %) | I 3 tilstande |
| LAMP2lysosome associated membrane protein 2 | Meget ofte (80–99 %) | I 2 tilstande |
| NIT1nitrilase 1 | Meget ofte (80–99 %) | I 1 tilstand |
| RYR2ryanodine receptor 2 | Meget ofte (80–99 %) | I 1 tilstand |
| TRDNtriadin | Meget ofte (80–99 %) | I 2 tilstande |
| ABCC9ATP binding cassette subfamily C member 9 | Ofte (30–79 %) | I 2 tilstande |
| ALG10BALG10 alpha-1,2-glucosyltransferase B | Ofte (30–79 %) | I 1 tilstand |
| CACNA1Ccalcium voltage-gated channel subunit alpha1 C | Ofte (30–79 %) | I 3 tilstande |
| CACNA1Dcalcium voltage-gated channel subunit alpha1 D | Ofte (30–79 %) | I 1 tilstand |
| CACNA2D1calcium voltage-gated channel auxiliary subunit alpha2delta 1 | Ofte (30–79 %) | I 2 tilstande |
| CACNB2calcium voltage-gated channel auxiliary subunit beta 2 | Ofte (30–79 %) | I 2 tilstande |
| CAV3caveolin 3 | Ofte (30–79 %) | I 1 tilstand |
| DBHdopamine beta-hydroxylase | Ofte (30–79 %) | I 1 tilstand |
| DLSTdihydrolipoamide S-succinyltransferase | Ofte (30–79 %) | I 1 tilstand |
| DNMT3ADNA methyltransferase 3 alpha | Ofte (30–79 %) | I 1 tilstand |
| DSC2desmocollin 2 | Ofte (30–79 %) | I 1 tilstand |
| ELNelastin | Ofte (30–79 %) | I 1 tilstand |
| EPAS1endothelial PAS domain protein 1 | Ofte (30–79 %) | I 1 tilstand |
| FHfumarate hydratase | Ofte (30–79 %) | I 1 tilstand |
| GATA4GATA binding protein 4 | Ofte (30–79 %) | I 2 tilstande |
| GATA5GATA binding protein 5 | Ofte (30–79 %) | I 1 tilstand |
| GATA6GATA binding protein 6 | Ofte (30–79 %) | I 2 tilstande |
| GJA5gap junction protein alpha 5 | Ofte (30–79 %) | I 1 tilstand |
| GPD1Lglycerol-3-phosphate dehydrogenase 1 like | Ofte (30–79 %) | I 2 tilstande |
| JUPjunction plakoglobin | Ofte (30–79 %) | I 2 tilstande |
Vis 99 gener mere
| Gen | Hvor ofte det ses | Tilstande |
|---|---|---|
| KCNA5potassium voltage-gated channel subfamily A member 5 | Ofte (30–79 %) | I 1 tilstand |
| KCND3potassium voltage-gated channel subfamily D member 3 | Ofte (30–79 %) | I 1 tilstand |
| KCNE2potassium voltage-gated channel subfamily E regulatory subunit 2 | Ofte (30–79 %) | I 2 tilstande |
| KCNE3potassium voltage-gated channel subfamily E regulatory subunit 3 | Ofte (30–79 %) | I 1 tilstand |
| KCNE5potassium voltage-gated channel subfamily E regulatory subunit 5 | Ofte (30–79 %) | I 1 tilstand |
| KCNH2potassium voltage-gated channel subfamily H member 2 | Ofte (30–79 %) | I 3 tilstande |
| KCNJ2potassium inwardly rectifying channel subfamily J member 2 | Ofte (30–79 %) | I 4 tilstande |
| KCNJ3potassium inwardly rectifying channel subfamily J member 3 | Ofte (30–79 %) | I 1 tilstand |
| KCNJ8potassium inwardly rectifying channel subfamily J member 8 | Ofte (30–79 %) | I 1 tilstand |
| KIF1Bkinesin family member 1B | Ofte (30–79 %) | I 1 tilstand |
| MAXMYC associated transcriptional regulator X | Ofte (30–79 %) | I 1 tilstand |
| MDH2malate dehydrogenase 2 | Ofte (30–79 %) | I 1 tilstand |
| MYL4myosin light chain 4 | Ofte (30–79 %) | I 1 tilstand |
| NF1neurofibromin 1 | Ofte (30–79 %) | I 1 tilstand |
| NKX2-5NK2 homeobox 5 | Ofte (30–79 %) | I 3 tilstande |
| NKX2-6NK2 homeobox 6 | Ofte (30–79 %) | I 1 tilstand |
| NPPAnatriuretic peptide A | Ofte (30–79 %) | I 2 tilstande |
| NUP155nucleoporin 155 | Ofte (30–79 %) | I 1 tilstand |
| PITX2paired like homeodomain 2 | Ofte (30–79 %) | I 1 tilstand |
| PKP2plakophilin 2 | Ofte (30–79 %) | I 2 tilstande |
| PRKAG2protein kinase AMP-activated non-catalytic subunit gamma 2 | Ofte (30–79 %) | I 2 tilstande |
| PSEN1presenilin 1 | Ofte (30–79 %) | I 1 tilstand |
| RANGRFRAN guanine nucleotide release factor | Ofte (30–79 %) | I 1 tilstand |
| RETret proto-oncogene | Ofte (30–79 %) | I 2 tilstande |
| SCN10Asodium voltage-gated channel alpha subunit 10 | Ofte (30–79 %) | I 1 tilstand |
| SCN1Bsodium voltage-gated channel beta subunit 1 | Ofte (30–79 %) | I 3 tilstande |
| SCN2Bsodium voltage-gated channel beta subunit 2 | Ofte (30–79 %) | I 2 tilstande |
| SCN3Bsodium voltage-gated channel beta subunit 3 | Ofte (30–79 %) | I 2 tilstande |
| SCN4Bsodium voltage-gated channel beta subunit 4 | Ofte (30–79 %) | I 1 tilstand |
| SCN5Asodium voltage-gated channel alpha subunit 5 | Ofte (30–79 %) | I 9 tilstande |
| SCNN1Asodium channel epithelial 1 subunit alpha | Ofte (30–79 %) | I 1 tilstand |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Ofte (30–79 %) | I 1 tilstand |
| SDHAF2succinate dehydrogenase complex assembly factor 2 | Ofte (30–79 %) | I 1 tilstand |
| SDHBsuccinate dehydrogenase complex iron sulfur subunit B | Ofte (30–79 %) | I 2 tilstande |
| SDHCsuccinate dehydrogenase complex subunit C | Ofte (30–79 %) | I 1 tilstand |
| SDHDsuccinate dehydrogenase complex subunit D | Ofte (30–79 %) | I 2 tilstande |
| SEMA3Asemaphorin 3A | Ofte (30–79 %) | I 1 tilstand |
| SLC25A11solute carrier family 25 member 11 | Ofte (30–79 %) | I 1 tilstand |
| SLMAPsarcolemma associated protein | Ofte (30–79 %) | I 1 tilstand |
| TECRLtrans-2,3-enoyl-CoA reductase like | Ofte (30–79 %) | I 1 tilstand |
| TMEM127transmembrane protein 127 | Ofte (30–79 %) | I 1 tilstand |
| TRPM4transient receptor potential cation channel subfamily M member 4 | Ofte (30–79 %) | I 3 tilstande |
| TTNtitin | Ofte (30–79 %) | I 1 tilstand |
| VHLvon Hippel-Lindau tumor suppressor | Ofte (30–79 %) | I 2 tilstande |
| ABCC8ATP binding cassette subfamily C member 8 | Nogle gange (5–29 %) | I 1 tilstand |
| ACTC1actin alpha cardiac muscle 1 | Nogle gange (5–29 %) | I 2 tilstande |
| ANK2ankyrin 2 | Nogle gange (5–29 %) | I 1 tilstand |
| ASXL1ASXL transcriptional regulator 1 | Nogle gange (5–29 %) | I 1 tilstand |
| CTSHcathepsin H | Nogle gange (5–29 %) | I 1 tilstand |
| DSPdesmoplakin | Nogle gange (5–29 %) | I 1 tilstand |
| GNB2G protein subunit beta 2 | Nogle gange (5–29 %) | I 1 tilstand |
| HCRThypocretin neuropeptide precursor | Nogle gange (5–29 %) | I 1 tilstand |
| HLA-DQB1major histocompatibility complex, class II, DQ beta 1 | Nogle gange (5–29 %) | I 1 tilstand |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Nogle gange (5–29 %) | I 1 tilstand |
| HNF1AHNF1 homeobox A | Nogle gange (5–29 %) | I 1 tilstand |
| JAK2Janus kinase 2 | Nogle gange (5–29 %) | I 1 tilstand |
| KCNJ11potassium inwardly rectifying channel subfamily J member 11 | Nogle gange (5–29 %) | I 1 tilstand |
| KITKIT proto-oncogene, receptor tyrosine kinase | Nogle gange (5–29 %) | I 1 tilstand |
| MOGmyelin oligodendrocyte glycoprotein | Nogle gange (5–29 %) | I 1 tilstand |
| MPLMPL proto-oncogene, thrombopoietin receptor | Nogle gange (5–29 %) | I 1 tilstand |
| MYBPC3myosin binding protein C3 | Nogle gange (5–29 %) | I 2 tilstande |
| MYOZ2myozenin 2 | Nogle gange (5–29 %) | I 1 tilstand |
| NOTCH2NLCnotch 2 N-terminal like C | Nogle gange (5–29 %) | I 1 tilstand |
| NTRK1neurotrophic receptor tyrosine kinase 1 | Nogle gange (5–29 %) | I 1 tilstand |
| P2RY11purinergic receptor P2Y11 | Nogle gange (5–29 %) | I 1 tilstand |
| PSEN2presenilin 2 | Nogle gange (5–29 %) | I 1 tilstand |
| RNF125ring finger protein 125 | Nogle gange (5–29 %) | I 1 tilstand |
| SLC4A3solute carrier family 4 member 3 | Nogle gange (5–29 %) | I 2 tilstande |
| SLC6A5solute carrier family 6 member 5 | Nogle gange (5–29 %) | I 1 tilstand |
| SRSF2serine and arginine rich splicing factor 2 | Nogle gange (5–29 %) | I 1 tilstand |
| TET2tet methylcytosine dioxygenase 2 | Nogle gange (5–29 %) | I 1 tilstand |
| THPOthrombopoietin | Nogle gange (5–29 %) | I 1 tilstand |
| TLL1tolloid like 1 | Nogle gange (5–29 %) | I 2 tilstande |
| TNFSF4TNF superfamily member 4 | Nogle gange (5–29 %) | I 1 tilstand |
| TNNC1troponin C1, slow skeletal and cardiac type | Nogle gange (5–29 %) | I 1 tilstand |
| TRIM63tripartite motif containing 63 | Nogle gange (5–29 %) | I 1 tilstand |
| UCP2uncoupling protein 2 | Nogle gange (5–29 %) | I 1 tilstand |
| ZNF365zinc finger protein 365 | Nogle gange (5–29 %) | I 1 tilstand |
| AKT1AKT serine/threonine kinase 1 | Sjældent (1–4%) | I 1 tilstand |
| BAP1BRCA1 associated deubiquitinase 1 | Sjældent (1–4%) | I 1 tilstand |
| CITED2Cbp/p300 interacting transactivator with ED-rich tail 2 | Sjældent (1–4%) | I 1 tilstand |
| CLCNKBchloride voltage-gated channel Kb | Sjældent (1–4%) | I 1 tilstand |
| FLNCfilamin C | Sjældent (1–4%) | I 1 tilstand |
| KIF20Akinesin family member 20A | Sjældent (1–4%) | I 1 tilstand |
| MYH6myosin heavy chain 6 | Sjældent (1–4%) | I 1 tilstand |
| MYPNmyopalladin | Sjældent (1–4%) | I 1 tilstand |
| NF2NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor | Sjældent (1–4%) | I 1 tilstand |
| PDGFBplatelet derived growth factor subunit B | Sjældent (1–4%) | I 1 tilstand |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Sjældent (1–4%) | I 1 tilstand |
| SLC12A3solute carrier family 12 member 3 | Sjældent (1–4%) | I 1 tilstand |
| SMARCB1SWI/SNF related BAF chromatin remodeling complex subunit B1 | Sjældent (1–4%) | I 1 tilstand |
| SMARCE1SWI/SNF related BAF chromatin remodeling complex subunit E1 | Sjældent (1–4%) | I 1 tilstand |
| SMOsmoothened, frizzled class receptor | Sjældent (1–4%) | I 1 tilstand |
| SUFUSUFU negative regulator of hedgehog signaling | Sjældent (1–4%) | I 1 tilstand |
| TBX20T-box transcription factor 20 | Sjældent (1–4%) | I 1 tilstand |
| TERTtelomerase reverse transcriptase | Sjældent (1–4%) | I 1 tilstand |
| TNNI3troponin I3, cardiac type | Sjældent (1–4%) | I 1 tilstand |
| TNNT2troponin T2, cardiac type | Sjældent (1–4%) | I 1 tilstand |
| TRAF7TNF receptor associated factor 7 | Sjældent (1–4%) | I 1 tilstand |
Hvor hyppigt det ses hos personer med en af genets tilstande, den hyppigste værdi på tværs af dem, sådan som Human Phenotype Ontology registrerer det. Disse sider beskriver egenskaber og den forskning, der ligger bag dem. De er ikke en diagnose, og hvis du har spørgsmål om symptomer, bør du spørge en læge eller genetisk rådgiver.
Snævrere træk
Bredere træk
Hvor oplysningerne kommer fra
- Human Phenotype Ontology, udgivelse 2026-09-01: egenskaben, dens navne, definition og de gener, der er knyttet til den. Læs mere på hpo.jax.org.
- Dataudgivelse 2026.10.16-c6eea6bf.
Én test. Svar for hele livet.
Fra 449 $Gratis forsendelse · Resultater på 6–8 uger